Detaljerad miljöinformation

Detailed background information

Due to the prescribed application regime of the medicine and its physical-chemical properties, the parent compound desflurane (CAS 57041-67-5) is mainly emitted to the air compartment. Indeed, a minor amount of desflurane and its metabolites fluoride and trifluoroacetic acid (TFA) are maybe emitted down-the-drain. Only the latter releases, parent and metabolite, have been examined in the following risk classification. Thus, only the potential risk to the aquatic compartment is addressed here.

Environmental Risk Classification

Predicted Environmental Concentration (PEC): parent compound

PEC is calculated according to the following formula:

PEC (μg/L) = (A*10⁹*(100-R))/(365*P*V*D*100) = 1.5*10^-6*A(100-R)

PEC = 0.000045 μg/L

Where:

A = 1466.9 kg * 0.02% (total sold amount API in Sweden year 2017, data from IQVIA (2018); reduced by fraction excreted). The 0.02% represents a worst-case assumption; Justification on reduction sees metabolism data below.

R = removal rate (due to loss by adsorption to sludge particles, by volatilization, hydrolysis or biodegradation) = 0 %. This value represents a worst-case assumption due to volatilisation; Justification sees data below.

P = number of inhabitants in Sweden = 9 *10⁶

V (L/day) = volume of wastewater per capita and day = 200 (ECHA default) (ECHA, 2016)

D = factor for dilution of waste water by surface water flow = 10 (ECHA default) (ECHA, 2016)

Predicted No Effect Concentration (PNEC): parent compound

Ecotoxicological studies

For desflurane information on aquatic toxicity is not available.

Algae:

Not available

Crustacean:

Acute toxicity

Not available

Chronic toxicity

Not available

Fish:

Acute toxicity

Not available

Chronic toxicity

Not available

Environmental risk classification (PEC/PNEC ratio): parent compound

Based on the fact that for desflurane information on aquatic toxicity is not available, the phrase “Risk of environmental impact of desflurane cannot be excluded, since no ecotoxicity data are available” has to be chosen.

However, according to the European Medicines Agency guideline on environmental risk assessment of medicinal products (EMA/CHMP/SWP/4447/00), use of desflurane is unlikely to represent a risk for the environment, because the predicted environmental concentration (PEC) is below the action limit 0.01 μg/L.

Moreover, the available information for the metabolite TFA (see below), justifies the phrase "Use of desflurane has been considered to result in insignificant risk."

Therefore, the use of desflurane under the prescribed application regime is unlikely to represent a risk for the environment, although, due to the missing of experimentally determined ecotoxicity data for the parent compound, an environmental impact of desflurane cannot be completely ruled out.

Overall, the distinct difference to the action limit for the parent compound as well as the low risk characterization ratio for the metabolite justifies the phrase "Use of desflurane has been considered to result in insignificant risk."

Predicted Environmental Concentration (PEC): metabolite TFA

PEC is calculated according to the following formula:

PEC (μg/L) = (A*10⁹*(100-R))/(365*P*V*D*100) = 1.5*10^-6*A(100-R)

PEC = 0.000030 μg/L

Where:

A = 1466.9 kg * 114.02 g/mol / 168.04 g/mol * 0.02% (total sold amount API in Sweden year 2017, data from IQVIA (2018); reduced by fraction excreted). The 0.02% represents a worst-case assumption; Justification on reduction sees metabolism data below.

R = removal rate (due to loss by adsorption to sludge particles, by volatilization, hydrolysis or biodegradation) = 0 %

P = number of inhabitants in Sweden = 9 *10⁶

V (L/day) = volume of wastewater per capita and day = 200 (ECHA default) (ECHA, 2016)

D = factor for dilution of waste water by surface water flow = 10 (ECHA default) (ECHA, 2016)

Predicted No Effect Concentration (PNEC): metabolite TFA

Ecotoxicological studies

Review of effects of TFA on environmental organisms is published by Solomon et al. (2016), which cites effect values based on biomass given by Berends et al (1999). A registration dossier under REACh is available on the ECHA website (ECHA, 2018) describing several aquatic toxicity studies with TFA (studies performed with sodium trifluoroacetate; concentrations re-calculated for TFA). It should be noted that the original study reports could not be evaluated. Instead, only information publicly disseminated on the ECHA website served as basis of this assessment. Therefore, definitive quality and reliability cannot be assessed from this limited information.

However, the registrants regarded the studies as reliable.

Algae:

Green alga (Pseudokirchneriella subcapita (synonym Raphidocelis subcapitata) formerly known as Selenastrum capricornutum) (OECD 201, GLP, including analytical monitoring) (ECHA, 2018)

EC50 72 h (growth rate) =237 mg/L

EC10 72 h (growth rate) = 5.6 mg/L

Marine alga (Phaeodactylum tricornutum) (OECD 201, GLP, no analytical monitoring, effect values based on nominal concentrations) (ECHA, 2018)

EC50 96 h (growth rate) > 97 mg/L

NOEC 96 h (growth rate) = 97 mg/L

Blue green alga (Anabaena flos-aquae) (US-EPA 540/09-82-020, GLP, including analytical monitoring, effect values based on nominal concentrations) (Smyth et al., 1994)

EC50 120 h (growth rate) > 1997 mg/L

NOEC 120 h (growth rate) = 499 mg/L

Crustacean (Daphnia magna):

Acute toxicity

EC50 48 h (immobility) > 999 mg/L (nominal concentration, OECD 202, GLP, limit test with 1200 mg/L sodium trifluoroacetate, including analytical monitoring)

Chronic toxicity

NOEC 21 days (reproduction rate, survival of adults) > 25 mg/L (nominal concentration, OECD 211, GLP, including analytical monitoring, no effect observed at highest concentration tested)

Fish:

Acute toxicity

Zebra fish (Danio rerio) LC50 96 h > 999 mg/L (nominal concentration, OECD 203, GLP, limit test with 1200 mg/L sodium trifluoroacetate, including analytical monitoring)

Chronic toxicity

No experimental results available

According to REACh Technical Guidance Document, Chapter R.10 (ECHA, 2008) an assessment factor of 50 applies to the lowest of two long term results (e.g. EC10 or NOECs) representing two trophic levels when such results have been generated covering that level showing the lowest L(E)C50 in the short-term tests. NOEC of the most recent study with the green alga Raphidocelis subcapitata has been used for this calculation since it is the most sensitive of the three tested species and the most reliable study. This PNEC is regarded a worst case estimate. For comparison, the REACh dossier derives a PNEC of 0.56 mg/L based on the EC10 of 5.6 mg/L and using an AF of 10.

PNEC_{surface water} = lowest NOEC/50 = 112 µg/L

Environmental risk classification (PEC/PNEC ratio): metabolite TFA

According to the European Medicines Agency guideline on environmental risk assessment of medicinal products (EMA/CHMP/SWP/4447/00), TFA as a relevant metabolite from the use of desflurane is unlikely to represent a risk for the environment, because the predicted environmental concentration (PEC) is below the action limit 0.01 μg/L.

Moreover, based on the available information for the metabolite TFA,

PEC/PNEC = 0.000030/112 = 0.00000027, i.e. PEC/PNEC ≤ 0.1 which justifies the phrase "Use of desflurane has been considered to result in insignificant risk."

Degradation

Biotic degradation

Ready degradability:

For desflurane studies on ready biodegradability are not available.

For the metabolite TFA biodegradation studies are presented in the REACh dossier (ECHA, 2012):

Test result: 0 % degradation within 28 days (OECD 301D).

These results indicate that desflurane as well as TFA can be regarded as not readily biodegradable.

Inherent degradability:

Information on inherent biodegradability of desflurane is not available.

For the metabolite TFA a modified SCAS Test is presented in the REACh dossier (ECHA, 2012) indicating that TFA is not biodegraded.

Simulation studies:

STP simulation studies and test results in water, sediment and total system are not available.

TFA was shown to be persistent in water compartments since it was not biodegraded during a year-long study using laboratory aquatic microcosms and ecosystem sediment-water systems (Ellis et al., 2001).

Abiotic degradation

Hydrolysis:

Information on hydrolysis is not available.

Photolysis:

Information on photolysis in water is not available.

Justification if R not equal to 0, e.g. modelling results using SimpleTreat:

As desflurane is not readily biodegradable, and simulation studies are not available, the default value was used for removal rate R = 0. However, this is considered to represent a worst-case approach for desflurane, as modelling results using SimpleTreat suggest that within STP about 93.2% is emitted to air, 0.9% to sludge, and only 5.9% to water.

As the metabolite TFA is not readily biodegradable, simulation studies are not available, and microcosms/field studies suggest persistence in the environment, the default value was used for removal rate R = 0. Modelling results using SimpleTreat suggest that within STP about 0.01% is emitted to air, 0.238% to sludge, and 99.8% to water.

Justification of chosen degradation phrase:

Based on the information that desflurane as well as its metabolite TFA are not readily biodegradable, and reliable simulation studies are not available, the phrase "desflurane is potentially persistent" is thus chosen.

Photodegradation:

In the atmosphere desflurane could be removed by chemical reaction with radicals, by photolysis and by wet or dry deposition. The degradation time is assumed to be limited by the reaction with the hydroxyl radical (OH). The following rate coefficients k_OH are described:

EpiSuite (estimation): 6E-15 cm³/molecule-sec at 298 K

Langbein et al. (1999): 4.4E-15 cm³/molecule-sec at 298 K

Sulbaek Andersen et al. (2010) 3.55E-15 cm³/molecule-sec at 272 K

Sulbaek Andersen et al. (2012) 3.7E-15 cm³/molecule-sec at 296 K

The life-times given in the literature are between 5.8 and 21.4 years depending on the rate constant, OH radical concentration, and temperature.

For TFA the estimated rate coefficient k_OH is 0.52E-012 cm³/molecule-sec at 298 K corresponding to a half-life of 31 d (EpiSuite, AOPWIN). The major elimination pathway of TFA in air is rainout.

Adsorption and desorption to soil

The soil adsorption coefficient (Koc) of desflurane was calculated by ACD/Labs to be 251 L/kg. Estimations via EpiSuite show Koc values of 97.54 L/kg (MCI method) and 31.5 L/kg. (Kow method with a logKow of 1.2). Using the logPow and the recommended QSAR of the TGD for non-hydrophobics, results in a Koc of 90.4 L/kg. Thus, adsorption of desflurane to soil and sediment is assumed to be low.

For TFA the soil adsorption coefficient (Koc) was estimated via EpiSuite. This estimation results in values of 3.231 L/kg (MCI method) and 2.706 L/kg. (Kow method with a logKow of 0.5). Using the logPow and the recommended QSAR of the TGD for non-hydrophobics, results in a Koc of 19.1 L/kg. However, the logPow and the Koc of this structure may be sensitive to pH, and thus may vary significantly. In a screening test presented in the REACh dossier (ECHA, 2012), no adsorption to three different standard soils was observed. In addition, in soil retention studies on a total of 54 soil samples the Kd were ranged between 0.17 to 20 L/kg for all soil location (Richey et al., 1997). The results indicate that retention of TFA by soil surfaces is dependent upon pH, soil organic matter and mineral surfaces and the presence of other anions in soil solution. Overall, TFA can be considered as a mobile organic compound in the majority of soils.

Volatilisation

Distribution of desflurane between air and water (Henry’s law constant) was estimated from the ratio of the vapour pressure to the water solubility. The calculated value of 7630 Pa m³/mole at 25 °C, resulting in an air-water partitioning coefficient of 1.54 at 12°C, indicates a rapid and significant volatilization from water.

For the metabolite TFA experimental Henrys law constants are presented in the REACh dossier (ECHA, 2018): the values ranges from 5800 mol/dm³/atm (Kutsuna and Hori, 2008) and 8950 mol/dm³/atm (Bowden et al., 1996) corresponding to a value of 0.00713 and 0.0112 Pa m³/mol at 25 °C, respectively. This indicates a very low the volatility potential of the metabolite.

Bioaccumulation

Bioconcentration factor (BCF):

An experimental bioconcentration study for desflurane is not available.

As well, an experimental bioconcentration study for the metabolite TFA is not available, that would enable the derivation of a reliable BCF. However, results on the incorporation of TFA into freshwater sediment organisms as well as estimation data (EpiSuite/BCFBAF) indicate only an insignificant potential for bioconcentration in aquatic species.

Partitioning coefficient:

An experimental study according to OECD 107 on the logPow of desflurane determined a logPow > 1.8 (Baxter, 2012). With the analytical method performed in this study it was not possible to detect desflurane in the water phase, thus no exact value could be determined. However, this experimentally determined lower limit of the logPow is similar to the calculated values of 1.88 at 25°C (ACD/Labs) and 1.2 (EpiSuite/KOWWIN v1.67).

Desflurane: estimated Log Dow = 1.88 at pH 7

For TFA estimated values for logPow of 0.5 (EpiSuite/KOWWIN v1.68) and 1.35 ± 0.38 (ACD/Labs) could be calculated. However, the partitioning is pH dependent as TFA dissociates in water and is expected to exist almost entirely in the anion form (dissociation constant pKa = 0.52); pH-dependence could be calculated using ACD/Labs.

TFA: estimated Log Dow = - 2.4 at pH 7

Justification of chosen bioaccumulation phrase:

Since log Dow < 4 at pH 7, desflurane has a low potential for bioaccumulation. Moreover, toxicokinetic data from humans show that desflurane does not remain in human bodies but is released back into the air.

Since log Dow < 4 at pH 7, TFA has a low potential for bioaccumulation.

Excretion (metabolism)

Desflurane predominantly leaves the human body via pulmonary exhalation and reaches the atmosphere as the main target compartment. Scientific literature demonstrates that the administered desflurane is mainly emitted unchanged into the atmosphere. Only a minor fraction of fluranes is excreted unchanged in urine (Saber and Sorig Hougaard, 2009).

The metabolism of desflurane has been comprehensively reviewed (Koblin, 1992; Kenna and van Pelt, 1994). Desflurane is metabolized to fluoride and trifluoroacetic acid (TFA), which is excreted via urine. The extent of desflurane metabolism has been estimated to be one-tenth that of isoflurane (Sutton et al., 1991), corresponding to approximately 0.02 – 0.2% (Kharasch, 1996), which is in alignment to SPC Sweden.

The portion of urinary organic fluorine is factor 5 below that of isoflurane (Sutton et al, 1991); for isoflurane the portion of organic fluorine is < 0.1% (Holaday and Fiserova-Bergerova, 1979). Thus, into wastewater, desflurane is excreted assuming all organic fluorine is unchanged parent or TFA – as a worst-case assumption - to < 0.02% as parent compound or as metabolite trifluoroacetic acid (TFA). The pharmacological activity of the metabolite is not known.

A reduction of A (total sold amount API in Sweden 2017) in the PEC calculation is justified based on excretion/metabolism as follows:

Desflurane (Parent):

A = 1466.9 kg * 0.02%

TFA (Metabolite):

A = 1466.9 kg * MW(metabolite)/MW(parent) * M

= 1466.9 kg * 114.02 g/mol / 168.04 g/mol * 0.02%

PBT/vPvB assessment

As both Desflurane and its metabolite TFA have low potential for bioaccumulation, they do not fulfil the criteria for PBT and/or vBvP substances and thus should not be flagged.

According to the established EU criteria, the medicine should not be regarded as a PBT/vPvB substance.

References

Baxter, 2012. Experimental study report: Desflurane, Partition Coefficient n-Octanol/Water (OECD 107), Shake Flask Method. Performed by Siemens AG, Prozess-Sicherheit, Industriepark Höchst, B 596 & B 598, 65926 Frankfurt am Main, Germany.

Berends AG, Boutonnet JC, De Rooij CG, and Thompson RS, 1999. Toxicity of trifluoroacetate to aquatic organisms. Environmental Toxicology and Chemistry. 18:1053–1059

Bowden DJ, Clegg SL and Brimblecombe P, 1996. The Henry's law constant of trifluoroacetic acid and its partitioning into liquid water in the atmosphere. Chemosphere, 32, 405-420

ECHA, European Chemicals Agency, 2008. Guidance on information requirements and chemical safety assessment. https://echa.europa.eu/documents/10162/13632/information_requirements_r10_en.pdf/bb902be7-a503-4ab7-9036-d866b8ddce69

ECHA, European Chemicals Agency, 2016. Guidance on information requirements and chemical safety assessment chapter R.16: Environmental exposure assessment version 3.0 February 2016. https://echa.europa.eu/documents/10162/13632/information_requirements_r16_en.pdf/b9f0f406-ff5f-4315-908e-e5f83115d6af

ECHA, European Chemicals Agency, 2018. REACH-Registrationdossier trifluoroacetic acid (CAS 76-05-1), last modified 2018-11-14. European Chemicals Agency, Helsinki, Finland. Publicly available under: https://www.echa.europa.eu/web/guest/registration-dossier/-/registered-dossier/5203

Ellis DA, Hanson ML, Sibley PK, Shahid T, Fineberg NA, Solomon KR, Muir DC and Mabury SA, 2001. The fate and persistence of trifluoroacetic and chloroacetic acids in pond waters. Chemosphere, 42, 309-318.

Holaday DA, Fiserova-Bergerova V, 1979. "Fate of fluorinated metabolites of inhalation anesthetics in man." Drug Metab Rev 9(1): 61-78.

IQVIA, 2018. Consumption assessment in kg for input to enviromental classification - updated 2018 (data 2017), Project 1048212

Kenna JG and van Pelt FNAM, 1994. The metabolism and toxicity of inhaled anaesthetic agents. Anaesthetic Pharmacology Review, 2, 29-42

Kharasch ED, 1996. Metabolism and toxicity of the new anesthetic agents. Acta Anaesthesiologica Belgica, 47, 7-14.

Koblin DD, 1992. Characteristics and implications of desflurane metabolism and toxicity. Anesth Analg, 75, S10-16

Kutsuna S and Hori H, 2008. Experimental determination of Henry's law constants of trifluoroacetic acid at 278–298 K. Atmospheric Environment, 42, 1399-1412

Langbein T, Sonntag H, Trapp D, Hoffmann A, Malms W, Roth EP, Mors V and Zellner R, 1999. Volatile anaesthetics and the atmosphere: atmospheric lifetimes and atmospheric effects of halothane, enflurane, isoflurane, desflurane and sevoflurane. British Journal of Anaesthesia, 82, 66-73

Richey DG, Driscoll CT and Likens GE, 1997. Soil Retention of Trifluoroacetate. Environ Sci Technol, 31, 1723-1727

Saber AT and Sorig Hougaard K, 2009. 141. Isoflurane, sevoflurane and desflurane. Arbete och Hälsa, 43

Smyth DV, Thompson R S, E Gillings1994. Sodium Trifluoroacetate: Toxicity to the Blue-green Alga, Anabaena Flos-aquae, and to the Freshwater Diatom, Navicula Pelliculosa, with Cover Letter dated 06/27/94. Brixham Environmental Lab., NTIS report: OTS0557458.

Solomon KR, Velders GJM, Wilson SR, Madronich S, Longstreth J, Aucamp PJ, Bornman JF. 2016. Sources, fates, toxicity, and risks of trifluoroacetic acid and its salts: Relevance to substances regulated under the montreal and kyoto protocols. Journal of Toxicology and Environmental Health - Part B: Critical Reviews. 19(7):289-304

Sulbaek Andersen MP, Nielsen OJ, Karpichev B, Wallington TJ and Sander SP, 2012. Atmospheric Chemistry of Isoflurane, Desflurane, and Sevoflurane: Kinetics and Mechanisms of Reactions with Chlorine Atoms and OH Radicals and Global Warming Potentials. J Phys Chem A. 116(24):5806-5820

Sulbaek Andersen MP, Sander SP, Nielsen OJ, Wagner DS, Sanford TJ, Jr. and Wallington TJ, 2010. Inhalation anaesthetics and climate change. British Journal of Anaesthesia, 105, 760-766.

Sutton TS, Koblin DD, Gruenke LD, Weiskopf RB, Rampil IJ, Waskell L and Eger EI, 2nd, 1991. Fluoride metabolites after prolonged exposure of volunteers and patients to desflurane. Anesth Analg, 73, 180-185